MangoRx vs Mochi Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Mochi Health scores higher on our rubric, 7.7/10 against 7.5/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MangoRx - from $299/mo →or find your match

Mochi Health beats MangoRx overall, scoring 7.7/10 vs 7.5/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; Mochi Health is from $178/mo. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a publicly traded company. Choose Mochi Health for users who want a tech-forward platform with app-based tracking.

A side-by-side look at MangoRx and Mochi Health to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MangoRx

#22 of 54

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Higher Rated

Mochi Health

#15 of 54

7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health

Feature	MangoRx	Mochi Health
Why each one	Oral dissolving tablets exclusively (zero injections) from a publicly traded company (NASDAQ: MGRX) with SEC-level financial transparency.	Flat-rate medication pricing at ALL dose levels ($99 semaglutide, $199 tirzepatide) plus registered dietitians and 4 different semaglutide formats.
Our Score	7.5/10	7.7/10
Headline Price	from $299/mo	from $178/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company	Users who want a tech-forward platform with app-based tracking
Watch out for	Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.	Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
Ranking	#22	#15
Get started	Visit MangoRx	Visit Mochi Health

Pros & Cons Compared

MangoRx

Pros

+Oral dissolving tablets exclusively, zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
−Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
−Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Mochi Health

Pros

+Flat $99/mo semaglutide at ALL dose levels, saves $100-200/mo vs competitors who charge more at higher doses
+4 semaglutide formats: injection, oral tablet, oral drops, and microdose, the most delivery options of any platform
+Registered dietitians included alongside physicians, not just medication, but nutritional support
+Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

−Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
−No refunds for payments made over 30 days ago, limited consumer protection window
−Relatively new company (founded 2022) with less track record than established platforms

Our Verdict

Mochi Health edges out MangoRx with a score of 7.7/10 vs 7.5/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; Mochi Health is from $178/mo.